Literature DB >> 23017691

Pulmonary nocardiosis in southern Taiwan.

Yi-Chun Chen1, Chen-Hsiang Lee2, Chun-Chih Chien3, Tsai-Ling Chao3, Wei-Che Lin4, Jien-Wei Liu5.   

Abstract

BACKGROUND/
PURPOSE: Nocardiosis mainly affects immunocompromised patients. The objectives of this study were to better understand the epidemiologic, demographic, clinical, and laboratory information in patients with pulmonary nocardiosis in southern Taiwan.
METHODS: Retrospective analyzing patients aged ≥18 years with culture-proven pulmonary nocardiosis received treatment at KCGMH between January 2004 and June 2010. Nocardiae were identified by 16S rRNA gene sequence analysis. Patients with pulmonary nocardiosis caused by the mostly commonly encountered Nocardia sp. were compared with those with pulmonary nocardiosis due to other Nocardia spp.
RESULTS: Among the 20 patients included, cough (80%) and fever (50%) were the 2 leading symptoms/signs, while lobar consolidation (50%) and pleural effusion (40%) were the most frequent radiographic manifestations. Eighteen patients (90%) had at least one underlying disease/condition. Nocardia cyriacigeorgica was most commonly found. Compared with those whose pathogens were other Nocardia spp., patients with pulmonary nocardiosis caused by N cyriacigeorgica experienced higher clinical severity as measured by APACHE II score (19.8 ± 7.0 vs. 12.8 ± 6.7; p = 0.04) and ICU admission rate (100% vs. 25%; p < 0.01). Thirteen patients (65%) turned out to be fatal. The severity (APACHE II score, 18 ± 6 vs. 10 ± 8; p = 0.02) and the proportion of acute and subacute pulmonary nocardiosis (76% vs. 0%, p = 0.03) between fatal and survived patients differed significantly.
CONCLUSIONS: N cyriacigeorgica was the most common pathogen in southern Taiwan. Higher mortality rate in patients with pulmonary nocardiosis was related to disease severity and acute and subacute infection.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Keywords:  Nocardia species; Outcome; Pulmonary nocardiosis; Radiographic findings

Mesh:

Year:  2012        PMID: 23017691     DOI: 10.1016/j.jmii.2012.07.017

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  14 in total

1.  Pulmonary nocardiosis: A Single Center Study.

Authors:  Bruno Miguel Oliveira Cabrita; Sílvia Correia; Sofia Jordão; R Correia de Abreu; Valquíria Alves; Bárbara Seabra; Jorge Ferreira
Journal:  Respir Med Case Rep       Date:  2020-07-25

2.  A case of empyema and septic arthritis due to Nocardia farcinica.

Authors:  Takashi Ishiguro; Hiroaki Yoshioka; Shoko Kawai; Shin-Ichi Katsumata; Tohru Gonoi; Noboru Takayanagi
Journal:  Clin Case Rep       Date:  2017-10-24

3.  Clinical Analysis of Pulmonary Nocardiosis in Patients With Autoimmune Disease.

Authors:  Shan Li; Xin Yu Song; Yu Yue Zhao; Kai Xu; Ya Lan Bi; Hui Huang; Zuo Jun Xu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

4.  Pulmonary nocardiosis caused by Nocardia cyriacigeorgica in patients with Mycobacterium avium complex lung disease: two case reports.

Authors:  Kazuma Yagi; Makoto Ishii; Ho Namkoong; Takahiro Asami; Hiroshi Fujiwara; Tomoyasu Nishimura; Fumitake Saito; Yoshifumi Kimizuka; Takanori Asakura; Shoji Suzuki; Tetsuro Kamo; Sadatomo Tasaka; Tohru Gonoi; Katsuhiko Kamei; Tomoko Betsuyaku; Naoki Hasegawa
Journal:  BMC Infect Dis       Date:  2014-12-10       Impact factor: 3.090

5.  Pulmonary nocardiosis in Chronic Obstructive Pulmonary Disease: A new clinical challenge.

Authors:  Giorgio Castellana; Anna Grimaldi; Marco Castellana; Claudio Farina; Giuseppe Castellana
Journal:  Respir Med Case Rep       Date:  2016-03-11

6.  Nocardiosis in the Tropical Northern Territory of Australia, 1997-2014.

Authors:  Sarah L McGuinness; Sarah E Whiting; Rob Baird; Bart J Currie; Anna P Ralph; Nicholas M Anstey; Ric N Price; Joshua S Davis; Steven Y C Tong
Journal:  Open Forum Infect Dis       Date:  2016-12-08       Impact factor: 3.835

7.  Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients.

Authors:  Julie Steinbrink; Joan Leavens; Carol A Kauffman; Marisa H Miceli
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

8.  Pulmonary Reinfection by Nocardia in an Immunocompetent Patient with Bronchiectasis.

Authors:  Junko Tamakoshi; Risa Kimura; Kosuke Takahashi; Hiroshi Saito
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

Review 9.  Isolated Nocardiosis, an Unrecognized Primary Immunodeficiency?

Authors:  Rubén Martínez-Barricarte
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

10.  Misdiagnosed tuberculosis being corrected as Nocardia farcinica infection by metagenomic sequencing: a case report.

Authors:  Lei Pan; Xiao-Hong Pan; Jie-Kun Xu; Xiao-Qing Huang; Jun-Ke Qiu; Cai-Hong Wang; Xiao-Bo Ji; Yang Zhou; Min-Jie Mao
Journal:  BMC Infect Dis       Date:  2021-08-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.